Autor:	Dietrich A. Stephan
Rok vydání:	2021
Předmět:	Economics and Econometrics Management of Technology and Innovation Biotechnology
Zdroj:	Journal of Commercial Biotechnology. 26
ISSN:	1478-565X 1462-8732
DOI:	10.5912/jcb995
Popis:	NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines which can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d45961dfd16a896961ab7571af3d3011 https://doi.org/10.5912/jcb995 Zobrazit plný text záznamu